Sweden’s Sobi has kicked off a rolling biologics license application in the US for SEL-212, vying to become a new option for patients with refractory chronic gout that doesn’t respond to current ...
Tools come in every shape and size imaginable, to be used in all types of tasks and situations. Many are very specialised, and the options can seem overwhelming. So which ones do you need in your ...
Looking for the best cash ISA rates in 2025? Trading 212 is offering The Independent readers an exclusive 4.51 per cent interest rate for the first 12 months (applicable only to contributions made in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results